No Detail Found!

Lipoatrophy as a manifestation of different clinical scenarios: corticosteroid injection, lupus profundus and morphea induced lipoatrophy

Author(s)
Khalifa E Sharquie Department of Dermatology, College of Medicine, University of Baghdad, Medical City Teaching Hospital, Baghdad, Iraq.
Faris O Hadi Department of Dermatology, Suq Alshuyukh General Hospital, Thiqar Health Directorate, Thiqar, Iraq.
Raed I Jabbar Department of Dermatology, Fallujah Teaching Hospital, Al-Anbar Health Directorate, Anbar, Iraq.
Abstract
Objective To report the frequency of different types of acquired dermolipoatrophy in relation to different etiological factors. Methods In this observational case series descriptive study, twenty nine patients with different clinical forms of acquired lipoatrophy were enrolled during the period from 2006-2020. For every patient, a full history and complete systemic and cutaneous examination were performed. Laboratory investigations were done, when needed. Results Twenty nine patients with localized lipoatrophy, 16 (55.2%) females, 13 (44.8%) males, with ages ranged from 3-55 years (mean 16.7 years) were evaluated and analyzed. The current work showed that intralesional and intramuscular triamcinolone injection was the most frequent cause responsible for development of localized lipoatrophy in 27 (93.1%) patients followed by morphea and lupus profundus in only 1 (3.45%) patient for each .With regard to corticosteroid induced lipoatrophy, the buttock was the most commonly affected site in 14 (51.9%) patients and all the affected patients were children while the scalp was involved in 12 (44.4%) patients and forearm in 1 (3.7%) patient. Conclusion Lipoatrophy following intramuscular and intralesional corticosteroid preparation particularly triamcinolone acetonide is an important and common cause for acquired lipoatrophy with significant psychological sequelae for the affected patients and/ or their parents. Also lupus profundus and linear morphea are important diseases to be considered while evaluating patients with acquired lipoatrophy.
Publication Details
Page(s) 485-492
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 32, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
Corticosteroids, Morphea, Triamcinolone, lupus profundus, Lipoatrophy
0

Citations

0

Downloads

67

Views